Abstract

Brain serotonin 5-HT 7 receptors are known to be expressed in neurons and astrocytes. We now report the presence of these receptors in a third type of cell, microglial cells. 5-Hydroxytryptamine (5-HT), 5-carboxamidotryptamine (5-CT), 5-methoxytryptamine (5-MeOT) and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) induced concentration-dependent stimulations of cAMP accumulation in the human microglial MC-3 cell line. The maximal effect of 5-HT was 3.4±0.3-fold stimulation (mean±S.E.M., n = 5 ) above basal levels. The rank order of agonist potency (pEC 50 values) was 5-CT (7.09)>5-HT (6.13)≥5-MeOT (5.78)≫8-OH-DPAT (ca. 5). The effect of 5-CT was inhibited in a concentration-dependent manner by the selective 5-HT 7 receptor antagonist SB-269970 (p A 2 value 9.03). Western blot analysis revealed the presence of immunoreactive bands corresponding to the human 5-HT 7 receptor in extracts of MC-3 cells. The presence of two splice variants of the 5-HT 7 receptor (5-HT 7(a/b)) was visualized by reverse transcriptase–polymerase chain reaction (RT–PCR) analysis with specific primers. In real-time PCR studies, the mRNA for interleukin-6 (IL-6) was found to be increased by 2.5-fold in MC-3 cells after 1 h incubation with 5-CT (1 μM) and this effect was fully blocked by the 5-HT 7 receptor antagonist SB-269970 (1 μM). These data show that functional 5-HT 7 receptors are present in human microglial MC-3 cells, suggesting that they are involved in neuroinflammatory processes.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.